550 related articles for article (PubMed ID: 19775399)
1. Factors leading to the biopsy of 1547 pigmented lesions at Mayo Clinic, Scottsdale, Arizona, in 2005.
Soares TF; Laman SD; Yiannias JA; Connolly SM; Lim KK; Wu Q; Swanson DL
Int J Dermatol; 2009 Oct; 48(10):1053-6. PubMed ID: 19775399
[TBL] [Abstract][Full Text] [Related]
2. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
3. Relative frequency of solitary melanocytic lesions of the oral mucosa.
Buchner A; Merrell PW; Carpenter WM
J Oral Pathol Med; 2004 Oct; 33(9):550-7. PubMed ID: 15357676
[TBL] [Abstract][Full Text] [Related]
4. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
Risser J; Pressley Z; Veledar E; Washington C; Chen SC
J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
[TBL] [Abstract][Full Text] [Related]
5. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan.
Saida T; Miyazaki A; Oguchi S; Ishihara Y; Yamazaki Y; Murase S; Yoshikawa S; Tsuchida T; Kawabata Y; Tamaki K
Arch Dermatol; 2004 Oct; 140(10):1233-8. PubMed ID: 15492186
[TBL] [Abstract][Full Text] [Related]
6. Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy.
Altamura D; Altobelli E; Micantonio T; Piccolo D; Fargnoli MC; Peris K
Arch Dermatol; 2006 Sep; 142(9):1123-8. PubMed ID: 16982999
[TBL] [Abstract][Full Text] [Related]
7. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
8. Dermoscopy patterns of halo nevi.
Kolm I; Di Stefani A; Hofmann-Wellenhof R; Fink-Puches R; Wolf IH; Richtig E; Smolle J; Kerl H; Soyer HP; Zalaudek I
Arch Dermatol; 2006 Dec; 142(12):1627-32. PubMed ID: 17178990
[TBL] [Abstract][Full Text] [Related]
9. Dermoscopy features of melanoma incognito: indications for biopsy.
Argenziano G; Zalaudek I; Ferrara G; Johr R; Langford D; Puig S; Soyer HP; Malvehy J
J Am Acad Dermatol; 2007 Mar; 56(3):508-13. PubMed ID: 17113189
[TBL] [Abstract][Full Text] [Related]
10. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols.
Argenziano G; Mordente I; Ferrara G; Sgambato A; Annese P; Zalaudek I
Br J Dermatol; 2008 Aug; 159(2):331-6. PubMed ID: 18510663
[TBL] [Abstract][Full Text] [Related]
11. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
Fisher NM; Schaffer JV; Berwick M; Bolognia JL
J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
[TBL] [Abstract][Full Text] [Related]
12. Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001.
Carli P; De Giorgi V; Crocetti E; Mannone F; Massi D; Chiarugi A; Giannotti B
Br J Dermatol; 2004 Apr; 150(4):687-92. PubMed ID: 15099364
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category.
Augsburger JJ; Corrêa ZM; Schneider S; Yassin RS; Robinson-Smith T; Ehya H; Trichopoulos N
Trans Am Ophthalmol Soc; 2002; 100():225-32; discussion 232-4. PubMed ID: 12545696
[TBL] [Abstract][Full Text] [Related]
14. The significance of eccentric and central hyperpigmentation, multifocal hyper/hypopigmentation, and the multicomponent pattern in melanocytic lesions lacking specific dermoscopic features of melanoma.
Arevalo A; Altamura D; Avramidis M; Blum A; Menzies S
Arch Dermatol; 2008 Nov; 144(11):1440-4. PubMed ID: 19015418
[TBL] [Abstract][Full Text] [Related]
15. Melanomas that failed dermoscopic detection: a combined clinicodermoscopic approach for not missing melanoma.
Puig S; Argenziano G; Zalaudek I; Ferrara G; Palou J; Massi D; Hofmann-Wellenhof R; Soyer HP; Malvehy J
Dermatol Surg; 2007 Oct; 33(10):1262-73. PubMed ID: 17903162
[TBL] [Abstract][Full Text] [Related]
16. Age- and site-specific variation in the dermoscopic patterns of congenital melanocytic nevi: an aid to accurate classification and assessment of melanocytic nevi.
Changchien L; Dusza SW; Agero AL; Korzenko AJ; Braun RP; Sachs D; Usman MH; Halpern AC; Marghoob AA
Arch Dermatol; 2007 Aug; 143(8):1007-14. PubMed ID: 17709659
[TBL] [Abstract][Full Text] [Related]
17. A retrospective cohort study of Southeast Asian patients with large congenital melanocytic nevi and the risk of melanoma development.
Chan YC; Giam YC
J Am Acad Dermatol; 2006 May; 54(5):778-82. PubMed ID: 16635657
[TBL] [Abstract][Full Text] [Related]
18. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
Yamaura M; Takata M; Miyazaki A; Saida T
Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study addressed to understanding what predicts severe histological dysplasia/early melanoma in excised atypical melanocytic lesions.
Strauss RM; Elliott F; Affleck P; Boon AP; Newton-Bishop JA
Br J Dermatol; 2007 Oct; 157(4):758-64. PubMed ID: 17714559
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
